2 research outputs found
Retreatment with trastuzumab in Her2-positive metastatic breast cancer patients: a clinical study
Objective: To study the benefit of trastuzumab in monotherapy or combined with different chemotherapeutic agents in the treatment for Her2+ metastatic breast cancer (MBC) patients after progression on prior trastuzumab therapy.Ye